Literature DB >> 6628564

Ultrastructural effects of Clostridium difficile toxin B on smooth muscle cells and fibroblasts.

N Wedel, P Toselli, C Pothoulakis, B Faris, P Oliver, C Franzblau, T LaMont.   

Abstract

The mechanism by which Clostridium difficile toxin B causes cells in culture to round was investigated. Cultured human lung fibroblasts and rabbit aortic smooth muscle cells were treated with partially purified or purified toxin B and monitored by light and transmission electron microscopy (TEM). Both preparations caused progressive cell rounding which correlated with disorganization of actin-containing myofilament bundles. Thin myofilaments became fragmented and finally disappeared (after 24 h) and dense bodies became more prominent, while all other organelles appeared unaffected.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6628564     DOI: 10.1016/0014-4827(83)90163-5

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Effect of Clostridium difficile enterotoxin A on ultrastructure of Chinese hamster ovary cells.

Authors:  V M Kushnaryov; J J Sedmak
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  Interaction of Clostridium difficile toxin A with cultured cells: cytoskeletal changes and nuclear polarization.

Authors:  C Fiorentini; W Malorni; S Paradisi; M Giuliano; P Mastrantonio; G Donelli
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Biochemical studies on the effect of Clostridium difficile toxin B on actin in vivo and in vitro.

Authors:  M J Mitchell; B E Laughon; S Lin
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

5.  Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication.

Authors:  Elaine E Hamm; Daniel E Voth; Jimmy D Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

Review 6.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

7.  Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B.

Authors:  S T Dillon; E J Rubin; M Yakubovich; C Pothoulakis; J T LaMont; L A Feig; R J Gilbert
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  Effects of Clostridium difficile toxin B on human monocytes and macrophages: possible relationship with cytoskeletal rearrangement.

Authors:  J C Siffert; O Baldacini; J G Kuhry; D Wachsmann; S Benabdelmoumene; A Faradji; H Monteil; P Poindron
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

9.  Differential cytotoxic effects of toxins A and B isolated from Clostridium difficile.

Authors:  S W Rothman; J E Brown; A Diecidue; D A Foret
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

10.  Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.

Authors:  Claribel P Taylor; Sanjeev Tummala; Deborah Molrine; Lisa Davidson; Richard J Farrell; Anthony Lembo; Patricia L Hibberd; Israel Lowy; Ciaran P Kelly
Journal:  Vaccine       Date:  2008-05-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.